Idexx Laboratories
(NASDAQ) IDXX
Idexx Laboratories Financials at a Glance
Market Cap
$43.83BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$4.45B
Net Income (TTM)
$1.10B
EPS (TTM)
$13.59
P/E Ratio
40.89
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$560.07
Volume
10,099
Open
$550.47
Price
$560.07
Volume
10,099
Open
$550.47
Previous Close
$555.67
Daily Range
$549.51 - $562.19
52-Week Range
$506.91 - $769.98
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$560.07
Volume
10,099
Open
$550.47
Previous Close
$555.67
Daily Range
$549.51 - $562.19
52-Week Range
$506.91 - $769.98
Estimated Earnings Date
Aug 4, 2026
IDXX News
IDXX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Idexx Laboratories
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
11,000
CEO
Jonathan J. Mazelsky, MBA
Website
www.idexx.comHeadquarters
Westbrook, ME 04092, US
IDXX Financials
Key Financial Metrics (TTM)
Gross Margin
62.05%
Operating Margin
31.63%
Net Income Margin
24.63%
Return on Equity
70.87%
Return on Capital
50.70%
Return on Assets
32.35%
Earnings Yield
2.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$43.83BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
78.88M
Volume
10.10K
Avg. Volume
632.74K
Financials (TTM)
Gross Profit
$2.76B
Operating Income
$1.41B
EBITDA
$1.56B
Operating Cash Flow
$1.21B
Capital Expenditure
-$126.63M
Free Cash Flow
$1.08B
Cash & ST Invst.
$200.53M
Total Debt
$1.11B
Idexx Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.14B
+14.3%
Gross Profit
$722.74M
+15.9%
Gross Margin
63.35%
N/A
Market Cap
$43.83BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.98M
N/A
Employees
11,000
N/A
Net Income
$278.45M
+14.7%
EBITDA
$400.87M
+13.9%
Quarterly Fundamentals
Total Cash
$200.53M
+22.3%
Total Debt
$1.11B
+4.4%
Accounts Receivable
$697.21M
+15.4%
Inventory
$382.40M
-3.4%
Long Term Debt
$398.60M
-27.1%
Short Term Debt
$706.85M
+37.9%
Return on Assets
32.35%
N/A
Return on Invested Capital
67.42%
N/A
Free Cash Flow
$234.26M
+12.7%
Operating Cash Flow
$266.25M
+11.9%